Nausea is one of the common gastrointestinal side effects of GLP-1 analogue use, especially with the short-acting analogues, but it tends to wane with time
While the study doesnt prove that GLP-1s cause these conditions, it adds to a growing body of research investigating how the medications may affect bone and joint health
But most peptides sold online are promoted for unproven uses, often combined in stacks, to purportedly heal injuries, build muscle, rejuvenate skin or increase energy
"Whenever we have a new medicine, we always restart the clock in terms of safety." In a response to Scientific American 's request for comment, the Eli Lilly spokesperson said that the FDA reviewed the company's "robust clinical data package" and that the approval establishes "Foundayo's strong safety and efficacy profile." Foundayo and other weight-loss drug candidates in the works could increase supply and help with affordability of GLP-1 drugs overallthough that might take some time, Horn says
a 25% target) at 68 weeks, well below expectations
Understanding ideal candidates helps researchers determine whether this stack aligns with their objectives
